PRESS RELEASES

11-Dec-2001	AMARIN CORPORATION PLC ANNOUNCES SALE OF TRANSDERMAL PATCH DEVELOPMENT UNIT IN ARGENTINA
12-Nov-2001	AMARIN CORPORATION ANNOUNCES EXECUTIVE APPOINTMENT
29-Oct-2001	AMARIN CORPORATION TO PRESENT AT SALOMON SMITH BARNEY 2001 HEALTH CARE CONFERENCE
29-Oct-2001	AMARIN CORPORATION PLC ANNOUNCES THIRD-QUARTER REVENUES
15-Oct-2001	AMARIN CORPORATION PLC ANNOUNCES DEPLOYMENT OF U.S. NEUROLOGY SALES FORCE
2-Oct-2001	AMARIN CORPORATION PLC EXCEEDS CASH FLOW TARGET ASSOCIATED WITH PRIVATE EQUITY PLACEMENT
20-Sep-2001	AMARIN CORPORATION PLC ANNOUNCES EXECUTIVE APPOINTMENTS
2-Aug-2001	FISCAL 2001 2ND QUARTER RESULTS
30-Jul-2001	AMARIN ANNOUNCES PARTNERSHIP WITH ELAN TO ESTABLISH PARKINSONS FRANCHISE
22-May-2001	AMARIN TO PRESENT AT UBS WARBURG GLOBAL SPECIALTY PHARMACEUTICALS CONFERENCE
3-May-2001	AMARIN, TEAM ANNOUNCE CO-PROMOTION AGREEMENT
1-May-2001	AMARIN CORPORATION PLC REPORTS FIRST QUARTER 2001 RESULTS
27-Mar-2001	AMARIN CORPORATION ACQUIRES ADDITIONAL ORAL CONTROLLED RELEASE TECHNOLOGIES
26-Feb-2001	FISCAL 2000 4TH QUARTER AND FULL YEAR RESULTS
23-Jan-2001	AMARIN CORPORATION APPOINTS MICHAEL COFFEE AS PRESIDENT AND CHIEF OPERATING OFFICER
4-Jan-2001	CENES LICENSES NORTH AMERICAN RIGHTS FOR MORAXEN TM TO AMARIN

Main Navigation